{"id":14000,"date":"2022-01-25T16:23:25","date_gmt":"2022-01-25T05:23:25","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=14000"},"modified":"2022-01-25T16:23:25","modified_gmt":"2022-01-25T05:23:25","slug":"atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/","title":{"rendered":"Tuy\u00ean b\u1ed1 c\u1ee7a ATAGI v\u1ec1 vi\u1ec7c s\u1eed d\u1ee5ng v\u1eafc xin Novavax COVID-19 (Nuvaxovid)"},"content":{"rendered":"<p><span data-contrast=\"auto\">Sau hai th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng giai \u0111o\u1ea1n 1 \u0111\u01b0\u1ee3c ti\u1ebfn h\u00e0nh \u1edf Hoa K\u1ef3\/Mexico v\u00e0 \u1edf V\u01b0\u01a1ng qu\u1ed1c Anh, C\u01a1 quan Qu\u1ea3n l\u00fd S\u1ea3n ph\u1ea9m Tr\u1ecb li\u1ec7u (TGA) \u0111\u00e3 c\u1ea5p ph\u00e9p t\u1ea1m th\u1eddi cho v\u1eafc xin COVID-19 c\u1ee7a Novavvax \u1edf \u00dac.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">V\u1eafc xin Novavax COVID-19, c\u00f2n \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 Nuvaxovid (Biocelect Pty Ltd\/Novavax Inc) l\u00e0 v\u1eafc xin d\u1ef1a tr\u00ean protein t\u0103ng \u0111\u1ed9t bi\u1ebfn v\u1edbi m\u1ed7i li\u1ec1u 0,5mL ch\u1ee9a 5 microgam protein t\u0103ng \u0111\u1ed9t bi\u1ebfn c\u1ee7a SARS-CoV-2 v\u00e0 50 microgam Matrix-M nh\u01b0 m\u1ed9t ch\u1ea5t b\u1ed5 tr\u1ee3.<\/span><\/p>\n<p><span data-contrast=\"auto\">V\u1eafc xin Novavax COVID-19 \u0111\u00e3 \u0111\u01b0\u1ee3c ch\u1ee9ng minh l\u00e0 c\u00f3 hi\u1ec7u qu\u1ea3 cao trong vi\u1ec7c ng\u0103n ng\u1eeba b\u1ec7nh COVID-19 c\u00f3 tri\u1ec7u ch\u1ee9ng \u1edf ng\u01b0\u1eddi l\u1edbn trong l\u1ecbch tr\u00ecnh ban \u0111\u1ea7u. ATAGI ti\u1ebfp t\u1ee5c theo d\u00f5i d\u1eef li\u1ec7u v\u1ec1 \u0111\u1ed9 an to\u00e0n, hi\u1ec7u qu\u1ea3 v\u00e0 kh\u1ea3 n\u0103ng sinh mi\u1ec5n d\u1ecbch c\u1ee7a v\u1eafc xin Novavax COVID-19 bao g\u1ed3m c\u1ea3 c\u00e1c nh\u00f3m \u01b0u ti\u00ean c\u00f3 nguy c\u01a1 cao v\u00e0 s\u1ebd cung c\u1ea5p c\u00e1c khuy\u1ebfn ngh\u1ecb c\u1eadp nh\u1eadt khi \u0111\u01b0\u1ee3c y\u00eau c\u1ea7u. <\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">\u0110\u1ec3 \u0111\u1ecdc to\u00e0n b\u1ed9 tuy\u00ean b\u1ed1 ATAGI, h\u00e3y theo li\u00ean k\u1ebft b\u00ean d\u01b0\u1edbi:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><br \/>\n<\/span><a href=\"https:\/\/www.health.gov.au\/news\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid#:~:text=ATAGI%20recommendations,minimum%20of%203%20weeks%20apart.\" target=\"_blank\" rel=\"noopener\"><span class=\"TextRun SCXW25492919 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW25492919 BCX0\">Tuy\u00ean b\u1ed1 c\u1ee7a ATAGI v\u1ec1 vi\u1ec7c s\u1eed d\u1ee5ng v\u1eafc xin Novavax COVID-19 (<\/span><span class=\"NormalTextRun SpellingErrorV2 SpellingErrorHighlight SCXW25492919 BCX0\">Nuvaxovid<\/span><span class=\"NormalTextRun SCXW25492919 BCX0\">)<\/span><\/span><span class=\"EOP SCXW25492919 BCX0\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Therapeutic Goods Administration (TGA) has granted provisional approval of the Novavvax COVID-19 vaccine in Australia.\u00a0<\/p>","protected":false},"author":493,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,8,10],"tags":[57,58,95,107],"class_list":["post-14000","post","type-post","status-publish","format-standard","hentry","category-news","category-covid-19","category-external","tag-covid-19-vaccine","tag-covid-19","tag-safety","tag-novavax"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid) - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"description\" content=\"Following two phase lll clinical trials, conducted in the USA\/Mexico and in the UK, the Therapeutic Goods Administration (TGA) has granted provisional approval of the Novavvax COVID-19 vaccine in Australia.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid) - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"Following two phase lll clinical trials, conducted in the USA\/Mexico and in the UK, the Therapeutic Goods Administration (TGA) has granted provisional approval of the Novavvax COVID-19 vaccine in Australia.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-25T05:23:25+00:00\" \/>\n<meta name=\"author\" content=\"Alice Black\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Black\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/\"},\"author\":{\"name\":\"Alice Black\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"headline\":\"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid)\",\"datePublished\":\"2022-01-25T05:23:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/\"},\"wordCount\":142,\"commentCount\":0,\"keywords\":[\"COVID-19 vaccine\",\"covid-19\",\"safety\",\"Novavax\"],\"articleSection\":[\"Show all\",\"COVID-19\",\"External News\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/\",\"name\":\"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid) - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2022-01-25T05:23:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"description\":\"Following two phase lll clinical trials, conducted in the USA\\\/Mexico and in the UK, the Therapeutic Goods Administration (TGA) has granted provisional approval of the Novavvax COVID-19 vaccine in Australia.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\",\"name\":\"Alice Black\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/vi\\\/author\\\/alice-black\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid) - The Melbourne Vaccine Education Centre (MVEC)","description":"Following two phase lll clinical trials, conducted in the USA\/Mexico and in the UK, the Therapeutic Goods Administration (TGA) has granted provisional approval of the Novavvax COVID-19 vaccine in Australia.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/","og_locale":"vi_VN","og_type":"article","og_title":"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid) - The Melbourne Vaccine Education Centre (MVEC)","og_description":"Following two phase lll clinical trials, conducted in the USA\/Mexico and in the UK, the Therapeutic Goods Administration (TGA) has granted provisional approval of the Novavvax COVID-19 vaccine in Australia.\u00a0","og_url":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2022-01-25T05:23:25+00:00","author":"Alice Black","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Alice Black","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"1 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/"},"author":{"name":"Alice Black","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"headline":"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid)","datePublished":"2022-01-25T05:23:25+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/"},"wordCount":142,"commentCount":0,"keywords":["COVID-19 vaccine","covid-19","safety","Novavax"],"articleSection":["Show all","COVID-19","External News"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/","url":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/","name":"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid) - The Melbourne Vaccine Education Centre (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2022-01-25T05:23:25+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"description":"Following two phase lll clinical trials, conducted in the USA\/Mexico and in the UK, the Therapeutic Goods Administration (TGA) has granted provisional approval of the Novavvax COVID-19 vaccine in Australia.\u00a0","breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"ATAGI Statement on the use of Novavax COVID-19 vaccine (Nuvaxovid)"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"Trung t\u00e2m gi\u00e1o d\u1ee5c v\u1eafc xin Melbourne (MVEC)","description":"T\u00ecm t\u1ea5t c\u1ea3 c\u00e1c th\u00f4ng tin li\u00ean quan \u0111\u1ebfn v\u1eafc-xin c\u1ee7a b\u1ea1n \u1edf \u0111\u00e2y.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311","name":"Alice \u0111en","url":"https:\/\/mvec.mcri.edu.au\/vi\/author\/alice-black\/"}]}},"modified_by":null,"_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/14000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/users\/493"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/comments?post=14000"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/14000\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/media?parent=14000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/categories?post=14000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/tags?post=14000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}